Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax immunotherapy for grass pollen allergy
NCT00413556Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jan 2007
- Primary completion
- Aug 2007
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of grass-pollen extract in allergic rhinitis due to grass pollen, sponsored by ALK-Abelló. Started Jan 2007; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT00413556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413556.